NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Shareholding Pattern: Shareholding Pattern Concord Drugs FY(Q2-Sep 2024-2025)

[fetch_key]
Shareholding results capture the distribution of ownership in a company as outlined in its financial disclosures. These results indicate the proportion of shares held by different investor categories and can reveal trends in market confidence. By studying shareholding results, investors and analysts can assess the influence of major shareholders on corporate governance and stock price movements. Concord Drugs has released its latest shareholding reports, covering the Second quarter and the fiscal year ending on (Q2-Sep 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
Shareholder Name Previous Quarter Quantity Current Quarter Quantity Previous Quarter Shares(in %) Current Quarter Shares(in %) Quarter to Quarter Difference
Promoters 55.41 Lakh 54.39 Lakh 55.41 54.39 -1.02 %
Public 44.59 Lakh 45.61 Lakh 44.59 45.61 +1.02 %
DII 0 0 0 0 0
FII 0 0 0 0 0
Government 0 0 0 0 0
Promoters’ shareholding decreased from 55.41% in June 2024 to 54.39% in September 2024. This reduction indicates that the promoters’ control over Company has weakened during this period.The percentage of shares held by the public increased from 44.59% in June 2024 to 45.61% in September 2024.This change suggests that the public’s investment in the company grew during the quarter.

Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.

Shareholder Name Previous Quarter Quantity Current Quarter Quantity Previous Quarter Shares (in %) Current Quarter Shares (in %) Quarter-to-Quarter Difference (%)
NAGI REDDY SEELAM 29.13 Lakh 28.61 Lakh 29.13 28.61 -0.52 %
SEELAM KONI REDDY 10.00 Lakh 9.51 Lakh 10 9.51 -0.49 %
NAGI REDDY SEELAM faced a downturn in stakeholding this quarter, witnessing a decline of -0.52 % in stakeholding compared to the previous quarter.SEELAM KONI REDDY faced a downturn in stakeholding this quarter, witnessing a decline of -0.49 % in stakeholding compared to the previous quarter.
Shareholder Name Previous Quarter Quantity Current Quarter Quantity Previous Quarter Shares (in %) Current Quarter Shares (in %) Quarter-to-Quarter Difference (%)
Resident Individuals holding nominal share capital up to Rs. 2 lakhs 27.49 Lakh 28.50 Lakh 27.49 28.5 + 1.01 %
Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs 16.82 Lakh 16.61 Lakh 16.82 16.61 -0.21 %
Non Resident Indians (NRIs) 19.78 K 42.29 K 0.2 0.42 + 0.22 %
Bodies Corporate 9.17 K 7.70 K 0.09 0.08 -0.01 %
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 1.01 %.Observations show a significant difference of -0.21 % in Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs’s financial performance between quarters.Leading the way to higher stakeholding, Non Resident Indians (NRIs) has significantly boosted stakeholding by an impressive 0.22 %.Observations show a significant difference of -0.01 % in Bodies Corporate’s financial performance between quarters.
[my_shortcode1 values=”Concord Drugs”]

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post